But slowing down digestion may affect your gut
Stay tuned for more updates on CagriSemas journey toward potential FDA approval, expected no earlier than late 2025, possibly initially for diabetes management
We beat major corporations in the private forums they think will protect them
Most patients can continue diabetes, weight loss GLP-1 drugs before surgery, those at highest risk for GI problems should follow liquid diet before procedure: New multi-society clinical practice guidance released
Adding a second injectable during this titration phase can obscure which agent is causing nausea, vomiting, or appetite changes, making it harder to adjust safely
Current Wegovy and Zepbound labeling specifically connects escalation schedules with reducing or managing gastrointestinal adverse reactions